Què significa "Esborrar"?
L'animal no porta la mutació. No desenvoluparà la malaltia i no ho transmetrà.
Discover the DNA test for Multifocal Retinopathy 2 (CMR2) in dogs, a crucial tool for early detection of this hereditary eye condition. CMR2 affects various breeds, leading to progressive vision loss. By identifying carriers and affected dogs, breeders can make informed breeding decisions, promoting healthier litters. This genetic test is simple, requiring just a cheek swab or blood sample, ensuring a hassle-free experience for pet owners. Early diagnosis allows for better management and care, enhancing your dog's quality of life. Invest in the CMR2 DNA test today to safeguard your furry friend’s vision and well-being. Protect your dog's future with proactive health measures!
Multifocal Retinopathy 2 (CMR2) is a genetic disorder affecting dogs, particularly certain breeds like the American Cocker Spaniel and the English Cocker Spaniel. This condition leads to progressive retinal deterioration, causing vision impairment or blindness over time. DNA testing for CMR2 allows breeders and pet owners to identify carriers and affected dogs, helping to manage and reduce the risk of passing the condition to future generations. Early detection through genetic testing is crucial in planning appropriate care and support for affected animals. By understanding CMR2, owners can make informed choices about breeding and health management for their pets.
Aquesta prova d'ADN s'inclou a partir del nostre pack Basic — i també forma part dels packs Basic, Standard, Advanced, Complete.
Veure paquets de proves d'ADN →Multifocal Retinopathy 2 (CMR2) is a genetic eye disorder that affects dogs, leading to significant visual impairment. This condition is characterized by the presence of multiple lesions in the retina, which can result in retinal detachment and progressive vision loss. CMR2 is caused by mutations in specific genes that play a crucial role in retinal health and function.
Dogs affected by CMR2 may exhibit a variety of clinical signs, including difficulty seeing in low light conditions, an apparent lack of visual tracking, and an increase in clumsiness or disorientation. As the disease progresses, these symptoms may become more pronounced, leading to total blindness in severe cases. Early detection is critical for managing the condition and providing appropriate care.
To confirm a diagnosis of CMR2, veterinarians typically utilize a combination of clinical examination and advanced imaging techniques. Fundoscopic examination allows for visualization of the retina, where characteristic lesions can be identified. In addition, genetic testing can be performed to identify the specific mutations associated with CMR2, providing definitive confirmation of the diagnosis.
Currently, there is no cure for Multifocal Retinopathy 2; however, management strategies can be implemented to enhance the quality of life for affected dogs. Regular veterinary check-ups and monitoring of the condition are essential. Supportive care may include environmental modifications to help the dog navigate its surroundings safely and the use of supplements aimed at promoting overall eye health.
Genetic testing for CMR2 plays a vital role in responsible breeding practices. By identifying carriers of the mutation, breeders can make informed decisions to reduce the prevalence of the disorder in future generations. This proactive approach not only helps in minimizing the risk of CMR2 in puppies but also contributes to the overall health and well-being of the breed.
Multifocal Retinopathy 2 is a serious condition that requires attention from dog owners, breeders, and veterinarians. Early identification through genetic testing and regular eye examinations can make a significant difference in managing the disease, allowing affected dogs to live fulfilling lives despite their visual challenges. Awareness and education about CMR2 are essential for promoting better outcomes within the canine population.
L'animal no porta la mutació. No desenvoluparà la malaltia i no ho transmetrà.
No. L'animal és generalment sa, però pot transmetre la mutació al seu descendència.
Porta dues còpies mutades. S'esperen signes clínics segons la malaltia. No s'ha de criar.
Algunes malalties estan lligades al sexe, de manera que la seva expressió varia en funció de la sexe de l'animal.
This DNA test detects the mutation associated with Multifocal Retinopathy 2 (CMR2) in order to identify clear, carrier, or at-risk animals.
Les proves d'ADN ajuden els criadors a planificar aparellaments més segurs i reduir el risc de transmetre la mutació a la descendència.
El mode d'herència informat per a aquesta prova és autosòmic recessiu.
This test analyses the mutation BEST1 c.482G>A.
No necessàriament. La interpretació depèn del patró d'herència i del genotip resultant.
Guziewicz Karina E, Zangerl Barbara, Lindauer Sarah J, Mullins Robert F, Sandmeyer Lynne S, Grahn Bruce H, Stone Edwin M, Acland Gregory M, Aguirre Gustavo D. Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for best disease. Invest Ophthalmol Vis Sci. 2007 May;48(5):1959-67. doi: 10.1167/iovs.06-1374.
La teva privadesa, la teva elecció
Utilitzem cookies essencials per executar el lloc web. Les galetes opcionals (com ara els proveïdors de contingut incrustat) estan desactivades per defecte i només s'activen si hi accepteu. Podeu canviar la vostra elecció en qualsevol moment mitjançant el botó "Cookies".
Necessari per a les funcions bàsiques i la seguretat. Sempre habilitat.
Millora funcions com ara l'emmagatzematge de preferències o les insercions no publicitàries.
Ens ajuda a entendre l'ús del lloc. Desactivat per defecte.
Publicitat/seguiment a través de llocs (alguns vídeos/mapes incrustats). Desactivat per defecte.